Transcatheter aortic valve implantation versus surgical aortic valve replacement: A propensity score analysis in patients at high surgical risk Lenard Conradi, MD, Moritz Seiffert, MD, Hendrik Treede, MD, Miriam Silaschi, Stephan Baldus, MD, Johannes Schirmer, MD, Jan-Felix Kersten, Thomas Meinertz, MD, Hermann Reichenspurner, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 143, Issue 1, Pages 64-71 (January 2012) DOI: 10.1016/j.jtcvs.2011.08.047 Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 Kaplan-Meier survival curves for patients receiving TAVI compared to a surgical control group after AVR. During a follow-up of 180 days, no statistically significant differences were noted. TAVI, Transapical antegrade aortic valve implantation; AVR, aortic valve replacement. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 64-71DOI: (10.1016/j.jtcvs.2011.08.047) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions
Figure 2 Kaplan-Meier analysis for survival free of major adverse cardiac and cerebrovascular events (ie, death, stroke, acute myocardial infarction, reoperation). Event rates were similar between the 2 cohorts. TAVI, Transapical antegrade aortic valve implantation; AVR, aortic valve replacement. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 64-71DOI: (10.1016/j.jtcvs.2011.08.047) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions